000 | 01349 a2200349 4500 | ||
---|---|---|---|
005 | 20250516231034.0 | ||
264 | 0 | _c20150511 | |
008 | 201505s 0 0 eng d | ||
022 | _a1940-6029 | ||
024 | 7 |
_a10.1007/978-1-4939-0956-8_10 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLymperopoulos, Anastasios | |
245 | 0 | 0 |
_aPharmacogenomics of heart failure. _h[electronic resource] |
260 |
_bMethods in molecular biology (Clifton, N.J.) _c2014 |
||
300 |
_a245-57 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aG-Protein-Coupled Receptor Kinase 5 _xgenetics |
650 | 0 | 4 | _aGenetic Variation |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPeptidyl-Dipeptidase A _xgenetics |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 |
_aReceptors, Adrenergic, alpha _xgenetics |
650 | 0 | 4 |
_aReceptors, Adrenergic, beta _xgenetics |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aFrench, Faren | |
773 | 0 |
_tMethods in molecular biology (Clifton, N.J.) _gvol. 1175 _gp. 245-57 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-1-4939-0956-8_10 _zAvailable from publisher's website |
999 |
_c24124292 _d24124292 |